Antidepressants for irritable bowel syndrome: reappraisal for the nondepressed

Affiliations

Comment

Lauren B Gerson. Gastroenterology. 2010 Feb.

. 2010 Feb;138(2):775-7.

doi: 10.1053/j.gastro.2009.12.015. Epub 2009 Dec 21.

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.

No abstract available

Comment on

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Ford AC, et al. Gut. 2009 Mar;58(3):367-78. doi: 10.1136/gut.2008.163162. Epub 2008 Nov 10. Gut. 2009. PMID: 19001059

Meta-analysis: The treatment of irritable bowel syndrome.
Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL. Lesbros-Pantoflickova D, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1253-69. doi: 10.1111/j.1365-2036.2004.02267.x. Aliment Pharmacol Ther. 2004. PMID: 15606387
A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
Sperber AD, Shvartzman P, Friger M, Fich A. Sperber AD, et al. Eur J Gastroenterol Hepatol. 2007 Jun;19(6):441-7. doi: 10.1097/MEG.0b013e32801140e2. Eur J Gastroenterol Hepatol. 2007. PMID: 17489053
Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
[No authors listed] [No authors listed] Prescrire Int. 2009 Apr;18(100):75-9. Prescrire Int. 2009. PMID: 19585728
Irritable bowel syndrome: new and emerging therapies.
Harris LA, Chang L. Harris LA, et al. Curr Opin Gastroenterol. 2006 Mar;22(2):128-35. doi: 10.1097/01.mog.0000208461.84513.f3. Curr Opin Gastroenterol. 2006. PMID: 16462168 Review.
[Treatment of the irritable bowel syndrome from the point of conclusive medicine].
Rumiantsev VG. Rumiantsev VG. Eksp Klin Gastroenterol. 2005;(1):32-7, 106. Eksp Klin Gastroenterol. 2005. PMID: 15991850 Review. Russian.